All In MedTech

Device Trial Radar · NCT05536336

Clinical Study to Evaluate the Performance of Synthetic Polyurethane Male Condoms

A Randomized, Double-Blinded, Crossover and Multi-center Clinical Study to Evaluate the Performance of Synthetic Polyurethane Male Condom Compared to Standard Latex Condom During Vaginal Intercourse

Last checked: Nov 19, 2026Latest source record: Mar 20, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedPivotal-lookingRandomized with 188 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

188

Actual

Start

Sep 8, 2022

Primary completion

Jul 12, 2023

Study completion Jun 27, 2024

Sponsor

Lead sponsor
Okamoto Industries, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
NAMSA
First posted
Sep 10, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Crossover
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study is a randomized, double-blinded, crossover and multi-center study to evaluate the clinical breakage and slippage of a new synthetic polyurethane male condom compared to a commercially available standard latex condom.

Conditions

  • Performance of Synthetic Polyurethane Male Condom

Interventions

  • CondomDevice

    Contraception

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The total clinical failure rates for the test and control condomsTime frame: 6 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Physicians Research Group

    Mesa, Arizona

  • Angels Clinical Research Center

    Miami, Florida

  • Physicians Research Group

    West Lafayette, Indiana

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.